![Paul Biondi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 348 571 $ al 31/05/2026
Mr. Paul R.
Biondi is an Independent Director at Seres Therapeutics, Inc., a Managing Partner at Flagship Pioneering, Inc., a Chairman-Elect at Princeton Family YMCA, an Executive Chairman at Valo Health LLC and an Executive Chairman at Valo Health, Inc. He is on the Board of Directors at Seres Therapeutics, Inc. Mr. Biondi was previously employed as a Senior VP, Head Strategy & Business Development by Bristol Myers Squibb Co. He also served on the board at ZymoGenetics, Inc. He received his undergraduate degree from Dartmouth College and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SERES THERAPEUTICS INC 0,49 % | 10/04/2025 | 47.619 ( 0,49 % ) | 348 571 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SERES THERAPEUTICS, INC. | Director/Miembro de la Junta | 20/03/2020 |
Princeton Family YMCA
 Princeton Family YMCA Investment Trusts/Mutual FundsMiscellaneous Operates as a charitable, not-for-profit community organization | Presidente | - |
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Presidente | - |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Inversor de Capital Privado | 01/07/2024 |
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2015 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Princeton Family YMCA
Princeton Family YMCA Investment Trusts/Mutual FundsMiscellaneous Operates as a charitable, not-for-profit community organization | Miscellaneous |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
